the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Amendments to Police Act involve changes to 10 clauses

KUALA LUMPUR: Amendments to the Police Act 1967 (Act 344) will involve changes to 10 clauses, including the insertion of a new Section 6A stipulating that the Yang di-Pertuan Agong shall be the Honorary Commissioner-in-Chief of the Royal Malaysia Police.

According to the blue draft distributed in Parliament today, the provision involves the amendment to Clause 2 of the Act.

Clause 4 seeks to amend Section 21 providing for the obligation of police officers to carry out escort duties on any public road, and any person who obstructs, opposes or fails to comply with police instructions may be fined up to RM10,000 and imprisoned for up to two years compared to the previous penalty of RM200 and two months imprisonment.

The amendment to Clause 5, on the other hand, seeks to increase the maximum fine from RM1,000 to RM2,000 for any person who fails to comply with a police order to stop before reaching any barrier erected or placed by any police officer, stipulated under Section 26.

Clause 6 is also amended involving changes to Section 66, which stipulates that any employer who fails to re-employ any reserve police officer is liable to a maximum fine of RM2,000 and a one-year jail term compared to RM1,000 and six months imprisonment previously.

It also provides that any police officer who fails to report for duty for 14 consecutive days without reasonable cause shall be deemed to have deserted and shall be guilty of an offence, an amendment to Section 86.

The First Schedule to the Act also seeks to delete the reference to Senior Inspector as the position is no longer used in the ranks of the police force.

Earlier, the first reading of the amendments was presented in the Dewan Rakyat by Deputy Home Minister Datuk Seri Dr Shamsul Anuar Nasarah, and the second and third readings are scheduled to be carried out in this session. –Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings